Gujarat Winding (541627)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at P/B of 0.35, a 65% discount to book value of ₹9.98 per share
• Market cap is just ₹4 Cr, so even modest asset monetization could move the needle
• ROCE is positive at 1.92%, suggesting some capital is not entirely idle despite negative ROE
• Accounting book value provides a potential cushion if assets hold their stated worth

Concerns

• Latest quarter sales and net profit are effectively zero, leaving no visible revenue engine
• Profit growth of -160% and ROE of -8.77% point to deteriorating economics
• Piotroski F-Score of 3/9 signals weak financial health
• Current price of ₹3.45 is below the stated 52-week range of ₹5.62-10.50, indicating severe weakness or data inconsistency

AI Analysis

At ₹3.45, this is the kind of stock that would make a bargain hunter pause. The book value is ₹9.98 per share, so the market is pricing the company at barely a third of its stated net worth. That is the classic Graham asset play setup. But let me be honest: a cheap price is not the same as a good investment. This business has no sales and no profit in the latest quarter. Sales growth is zero, and profit growth is -160%, which means losses have gotten worse. With return on equity at -8.77%, every rupee of equity is earning less than nothing. The Piotroski F-Score of 3/9 tells me the financial health is weak. I cannot rely on a company that cannot generate revenue. I do not know what competitive advantage exists in paper and paper products; a commodity business without sales is a shell. The share price is even below the stated 52-week range, which suggests thin trading or a broken stock. In Buffett's words: it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. This may be a fair company at a cheap price, but with no earnings, no dividend, and no growth, I am not willing to call it wonderful. Graham would demand a margin of safety, and at a 65% discount to book there is some accounting margin, but the business itself is bleeding. I would need to see sales restart, costs controlled, and evidence that the productive assets can generate positive returns. Until then, it is a possible asset play, not a compounder. I would rather wait.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer